Ongoing research investigates its mechanisms and future applications for stress management in controlled laboratory settings
GDF-8: A New Era in Muscle Growth Therapies is Coming to Market On November 14, 2025, Scholar Rock released its third-quarter financial and pipeline update, announcing that it had held a constructive, face-to-face Type A meeting with the FDA regarding the BLA for its core asset, Apitegromab, intended for the treatment of spinal muscular atrophy (SMA) in both children and adults
Don't rush the dose escalation The gradual increase (from 1.5 mg to 4 mg to 9 mg to 25 mg) exists for a reason
A Dexcom CGM was worn in outer space in first-of-its-kind Polaris Dawn Mission
These effects help patients: Lower blood sugar Lose weight Reduce cardiovascular risk Drugs in this class include: Ozempic (semaglutide, injectable) Rybelsus (oral semaglutide) Wegovy (semaglutide for weight loss) Trulicity (dulaglutide) Victoza (liraglutide) Ozempic and Rybelsus, in particular, have skyrocketed in popularity not only for diabetes management but also for off-label weight loss
These applications underscore the versatility and utility of GST-tagged proteins in fundamental research and applied sciences
